Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update

Paula Bolton‐Maggs(University of Manchester), Jacob C. Langer(University of Toronto), Achille Iolascon(University of Naples Federico II), Paul Tittensor(Cheshire West and Chester), May‐Jean King(NHS Blood and Transplant)
British Journal of Haematology
November 5, 2011
Cited by 392Open Access
Full Text

Abstract

Guidelines on hereditary spherocytosis (HS) published in 2004 (Bolton-Maggs et al, 2004) are here replaced to reflect changes in current opinion on the surgical management, (particularly the indications for concomitant splenectomy with cholecystectomy in children with mild HS, and concomitant cholecystectomy with splenectomy in those with asymptomatic gallstones). Further potential long term hazards of splenectomy are now recognised. Advances have been made in our understanding of the biochemistry of the red cell membrane which underpins the choice of tests. Biochemical assays of membranes proteins and genetic analysis may be indicated (rarely) to diagnose atypical cases. The diagnostic value of the eosin-5-maleimide (EMA) binding test has been validated in a number of studies with understanding of its limitations.


Related Papers

No related papers found

Powered by citation graph analysis